Core Insights - Scorpius Holdings, Inc. is implementing a strategic restructuring initiative aimed at achieving over $6 million in annual cost savings through operational realignment and workforce reduction [1][2][3] - The company is exploring opportunities to establish a halal-certified biomanufacturing presence in Malaysia, targeting the underserved global Muslim population [4][5][6] - A new board member, Tan Sze Thuan, has been appointed to support the company's growth and global expansion strategy, particularly in Southeast Asia [7][8] Cost Optimization - The operational realignment includes a 28% reduction in headcount and the closing of North Carolina facilities to consolidate operations [2][4] - These measures are designed to improve capital efficiency while maintaining high-quality service delivery to clients [3][4] International Expansion - Scorpius is in preliminary discussions with Malaysian stakeholders to form a subsidiary focused on halal-compliant biomanufacturing [4][5] - The initiative aims to address the unmet need for halal-certified biopharmaceutical products within the 2 billion global Muslim population [5][6] Leadership and Governance - The appointment of Tan Sze Thuan is expected to enhance the company's ability to navigate partnerships and regulatory engagement in Southeast Asia [7][8] - This move aligns with the company's commitment to building a world-class board to guide its growth and international expansion [8]

SAN ANTONIO, April 30, 2025 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (OTC: SCPX) (“Scorpius” or “the Company”), an integrated contract development and manufacturing organization ("CDMO”), today provided strategic, financial, and operational updates for the year ended December 31, 2024. Jeff Wolf, CEO of Scorpius Holdings, Inc., stated, "The current biotech funding environment has created real headwinds for many of our clients, particularly when it comes to advancing drug development and clinical trials. I ...